182 related articles for article (PubMed ID: 36034864)
1. Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design.
D'Ercole A; Nistri S; Pacini L; Carotenuto A; Santoro F; Papini AM; Bathgate RAD; Bani D; Rovero P
Front Pharmacol; 2022; 13():942178. PubMed ID: 36034864
[TBL] [Abstract][Full Text] [Related]
2. The anti-fibrotic actions of relaxin are mediated through AT
Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a new potent and long-lasting single chain peptide agonist of RXFP1 in cells and in vivo translational models.
Illiano S; Poirier B; Minoletti C; Pasquier O; Riva L; Chenede X; Menguy I; Guillotel M; Prigent P; Le Claire S; Gillot F; Thill G; Lo Presti F; Corbier A; Le Bail JC; Grailhe P; Monteagudo E; Ingenito R; Bianchi E; Philippo C; Duclos O; Mallart S; Bathgate R; Janiak P
Sci Rep; 2022 Nov; 12(1):20435. PubMed ID: 36443381
[TBL] [Abstract][Full Text] [Related]
4. In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.
McBride A; Hoy AM; Bamford MJ; Mossakowska DE; Ruediger MP; Griggs J; Desai S; Simpson K; Caballero-Hernandez I; Iredale JP; Pell T; Aucott RL; Holmes DS; Webster SP; Fallowfield JA
Sci Rep; 2017 Sep; 7(1):10806. PubMed ID: 28883402
[TBL] [Abstract][Full Text] [Related]
5. Porcine Relaxin but Not Serelaxin Shows Residual Bioactivity after In Vitro Simulated Intestinal Digestion-Clues for the Development of New Relaxin Peptide Agonists Suitable for Oral Delivery.
Pacini L; D'Ercole A; Papini AM; Bani D; Nistri S; Rovero P
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613489
[TBL] [Abstract][Full Text] [Related]
6. Human Recombinant Relaxin (Serelaxin) as Anti-fibrotic Agent: Pharmacology, Limitations and Actual Perspectives.
Sassoli C; Nistri S; Chellini F; Bani D
Curr Mol Med; 2022; 22(3):196-208. PubMed ID: 33687895
[TBL] [Abstract][Full Text] [Related]
7. Relaxin in hepatic fibrosis: What is known and where to head?
Ezhilarasan D
Biochimie; 2021 Aug; 187():144-151. PubMed ID: 34102254
[TBL] [Abstract][Full Text] [Related]
8. Relaxin Inhibits the Cardiac Myofibroblast NLRP3 Inflammasome as Part of Its Anti-Fibrotic Actions via the Angiotensin Type 2 and ATP (P2X7) Receptors.
Tapia Cáceres F; Gaspari TA; Hossain MA; Samuel CS
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806076
[TBL] [Abstract][Full Text] [Related]
9. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1.
Hossain MA; Kocan M; Yao ST; Royce SG; Nair VB; Siwek C; Patil NA; Harrison IP; Rosengren KJ; Selemidis S; Summers RJ; Wade JD; Bathgate RAD; Samuel CS
Chem Sci; 2016 Jun; 7(6):3805-3819. PubMed ID: 30155023
[TBL] [Abstract][Full Text] [Related]
10. Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology.
Agoulnik IU; Kaftanovskaya EM; Myhr C; Bathgate RAD; Kocan M; Peng Y; Lindsay RM; DiStefano PS; Agoulnik AI
Biochem Pharmacol; 2024 Jun; ():116401. PubMed ID: 38945278
[TBL] [Abstract][Full Text] [Related]
11. Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule Agonists.
Hu X; Myhr C; Huang Z; Xiao J; Barnaeva E; Ho BA; Agoulnik IU; Ferrer M; Marugan JJ; Southall N; Agoulnik AI
Biochemistry; 2016 Mar; 55(12):1772-83. PubMed ID: 26866459
[TBL] [Abstract][Full Text] [Related]
12. AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis.
Chow BSM; Kocan M; Shen M; Wang Y; Han L; Chew JY; Wang C; Bosnyak S; Mirabito-Colafella KM; Barsha G; Wigg B; Johnstone EKM; Hossain MA; Pfleger KDG; Denton KM; Widdop RE; Summers RJ; Bathgate RAD; Hewitson TD; Samuel CS
J Am Soc Nephrol; 2019 Nov; 30(11):2191-2207. PubMed ID: 31511361
[TBL] [Abstract][Full Text] [Related]
13. ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.
Kocan M; Sarwar M; Ang SY; Xiao J; Marugan JJ; Hossain MA; Wang C; Hutchinson DS; Samuel CS; Agoulnik AI; Bathgate RAD; Summers RJ
Sci Rep; 2017 Jun; 7(1):2968. PubMed ID: 28592882
[TBL] [Abstract][Full Text] [Related]
14. Investigation of interactions at the extracellular loops of the relaxin family peptide receptor 1 (RXFP1).
Diepenhorst NA; Petrie EJ; Chen CZ; Wang A; Hossain MA; Bathgate RA; Gooley PR
J Biol Chem; 2014 Dec; 289(50):34938-52. PubMed ID: 25352603
[TBL] [Abstract][Full Text] [Related]
15. Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1.
Hossain MA; Praveen P; Noorzi NA; Wu H; Harrison IP; Handley T; Selemidis S; Samuel CS; Bathgate RAD
ACS Pharmacol Transl Sci; 2023 May; 6(5):842-853. PubMed ID: 37200817
[TBL] [Abstract][Full Text] [Related]
16. R2R01: A long-acting single-chain peptide agonist of RXFP1 for renal and cardiovascular diseases.
Poirier B; Pasquier O; Chenede X; Corbier A; Prigent P; Azam A; Bernard C; Guillotel M; Gillot F; Riva L; Briand V; Ingenito R; Gauzy-Lazo L; Duclos O; Philippo C; Maillere B; Bianchi E; Mallart S; Janiak P; Illiano S
Br J Pharmacol; 2024 Jul; 181(13):1993-2011. PubMed ID: 38450758
[TBL] [Abstract][Full Text] [Related]
17. Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts.
Cáceres FT; Gaspari TA; Samuel CS; Pinar AA
FASEB J; 2019 Dec; 33(12):14717-14733. PubMed ID: 31689135
[TBL] [Abstract][Full Text] [Related]
18. Chimeric relaxin peptides highlight the role of the A-chain in the function of H2 relaxin.
Hossain MA; Wade JD; Bathgate RA
Peptides; 2012 May; 35(1):102-6. PubMed ID: 22414484
[TBL] [Abstract][Full Text] [Related]
19. Relaxin signaling activates peroxisome proliferator-activated receptor gamma.
Singh S; Bennett RG
Mol Cell Endocrinol; 2010 Feb; 315(1-2):239-45. PubMed ID: 19712722
[TBL] [Abstract][Full Text] [Related]
20. Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1.
Agoulnik AI; Agoulnik IU; Hu X; Marugan J
Br J Pharmacol; 2017 May; 174(10):977-989. PubMed ID: 27771940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
